Different doses of psilocybin produce distinct behavioral and brain-altering effects in mice, according to new research published in the Journal of Psychopharmacology. The study suggests that moderate ...

Researchers develop 4e, a psilocin derivative that provides sustained serotonin activity without the hallucinogenic effects of magic mushrooms.

New research reveals that psilocybin and MDMA promote long-term PTSD recovery by physically remodeling myelin insulation in ...

Post-traumatic stress disorder (PTSD) is not only characterized by strongly encoded traumatic memories, but also by disrupted coordination across brain networks. New research shows that treatment with ...

Post-traumatic stress disorder (PTSD) is not only characterized by strongly encoded traumatic memories, but also by disrupted coordination across brain networks. New research shows that treatment with ...

Issued on behalf of Helus PharmaVANCOUVER, BC, Feb. 27, 2026 /CNW/ -- Equity-Insider.com News Commentary -- Psychedelic compounds are edging closer to ...

Clinically meaningful data establishes proof of concept for elismetrep as a promising therapeutic candidate for migraine and its progression into registrational studies anticipated to initiate ...

New experiments suggest a biological missing link that helps lock in the long-term benefits of psychedelic-assisted PTSD treatment ...

Total 4Q and full year 2025 net product revenue of $196.0 million and $638.5 million, respectively,representing 65% and 66% year-over-year growth ...